Immunotherapy for glioblastoma: quo vadis? - Archive ouverte HAL Access content directly
Journal Articles Nature Reviews Clinical Oncology Year : 2019

Immunotherapy for glioblastoma: quo vadis?

(1, 2) , (3)
1
2
3

Abstract

No abstract available

Dates and versions

inserm-02941506 , version 1 (17-09-2020)

Identifiers

Cite

Michael Weller, Emilie Le Rhun. Immunotherapy for glioblastoma: quo vadis?. Nature Reviews Clinical Oncology, 2019, 16 (7), pp.405-406. ⟨10.1038/s41571-019-0195-3⟩. ⟨inserm-02941506⟩

Collections

INSERM
22 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More